Ecopipam Tablets to Study Tourette Syndrome in Children and Adolescents - Open Label Extension
Status:
Recruiting
Trial end date:
2022-11-01
Target enrollment:
Participant gender:
Summary
This study is an international, multicenter, open-label, long term extension study evaluating
the safety of ecopipam tablets for the treatment of children and adolescent subjects with
Tourette Syndrome.